Skip to main content
SpringerLink
Log in

Serum Concentration of Procollagen Type III Amino-Terminal Peptide is Increased in Patients with Successfully Repaired Coarctation of the Aorta with Left Ventricular Hypertrophy

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Pathological left ventricular hypertrophy (LVH) with myocardial fibrosis is an independent risk factor for cardiovascular mortality. Previous studies indicated that patients with coarctation of the aorta (CoA) have increased left ventricular mass (LVM) including LVH, even after successful CoA repair. It is unclear whether the increased LVM is pathological one with cardiac fibrosis. Group A consisted of 17 patients with successfully repaired CoA. Group B consisted of 17 postoperative subjects who matched the age and postoperative periods of group A. Group C comprised 28 subjects for the geometric standard of the left ventricle. The LVM index (LVMI) and the relative wall thickness (RWT) of group A and B were compared with the values of 17 age-matched subjects from group C. The serum concentration of procollagen type III amino-terminal peptide (P-III-P), a biomarker for myocardial fibrosis, in group A was compared with the concentration in group B. The correlations between the serum P-III-P concentration and LVMI and RWT were studied in group A and non-A group. In group A, RWT and LVMI were significantly higher than those in group C (0.37 ± 0.05 vs. 0.31 ± 0.02, p < 0.01; 44.8 ± 11.2 vs. 36.5 ± 7.6, p = 0.04, respectively), and the serum P-III-P concentration was significantly higher than that in group B (1.59 ± 0.74 vs. 1.07 ± 0.33, p = 0.04). Serum P-III-P concentrations were well correlated with RWT and LVMI (r = 0.89, p < 0.01; r = 0.63, p < 0.01, respectively) in group A. LVH in patients with successfully repaired CoA may have an abnormal pathogenesis associated with myocardial fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Brili S, Dernellis J, Aggeli C, Pitsavos C, Hatzos C, Stefanadis C et al (1998) Aortic elastic properties in patients with repaired coarctation of aorta. Am J Cardiol 82(1140–3):A10

    Google Scholar 

  2. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260

    Article  PubMed  Google Scholar 

  3. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062

    Article  PubMed  Google Scholar 

  4. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458

    Article  CAS  PubMed  Google Scholar 

  5. Diez J (2007) Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich) 9:546–550

    Article  CAS  Google Scholar 

  6. Diez J, Lopez B, Gonzalez A, Querejeta R (2001) Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 16:328–335

    Article  CAS  PubMed  Google Scholar 

  7. Eerola A, Jokinen E, Boldt T, Mattila IP, Pihkala JI (2007) Left ventricular hypertrophy persists after successful treatment for coarctation of the aorta. Scand Cardiovasc J 41:370–377

    Article  PubMed  Google Scholar 

  8. Foster BJ, Mackie AS, Mitsnefes M, Ali H, Mamber S, Colan SD (2008) A novel method of expressing left ventricular mass relative to body size in children. Circulation 117:2769–2775

    Article  PubMed  Google Scholar 

  9. Lammi L, Ryhanen L, Lakari E, Risteli J, Paakko P, Kahlos K et al (1999) Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med 159:818–823

    Article  CAS  PubMed  Google Scholar 

  10. Lawrie GM, DeBakey ME, Morris GC Jr, Crawford ES, Wagner WF, Glaeser DH (1981) Late repair of coarctation of the descending thoracic aorta in 190 patients. Results up to 30 years after operation. Arch Surg 116:1557–1560

    Article  CAS  PubMed  Google Scholar 

  11. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1989) Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 110:101–107

    Article  CAS  PubMed  Google Scholar 

  12. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566

    Article  CAS  PubMed  Google Scholar 

  13. Maron BJ, Humphries JO, Rowe RD, Mellits ED (1973) Prognosis of surgically corrected coarctation of the aorta. A 20-year postoperative appraisal. Circulation 47:119–126

    Article  CAS  PubMed  Google Scholar 

  14. Murakami T, Takeda A (2005) Enhanced aortic pressure wave reflection in patients after repair of aortic coarctation. Ann Thorac Surg 80:995–999

    Article  PubMed  Google Scholar 

  15. Nakahara T, Takata Y, Hirayama Y, Asano K, Adachi H, Shiokawa G et al (2007) Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide. Circ J 71:716–721

    Article  PubMed  Google Scholar 

  16. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M et al (2009) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32:3–107

    Article  CAS  PubMed  Google Scholar 

  17. Ou P, Celermajer DS, Jolivet O, Buyens F, Herment A, Sidi D et al (2008) Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair. Am Heart J 155:187–193

    Article  PubMed  Google Scholar 

  18. Robert V, Silvestre JS, Charlemagne D, Sabri A, Trouve P, Wassef M et al (1995) Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension 26:971–978

    Article  CAS  PubMed  Google Scholar 

  19. Sasaguri M, Noda K, Tashiro E, Notomo J, Tsuji E, Koga M et al (2000) The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients. Hypertens Res 23:317–322

    Article  CAS  PubMed  Google Scholar 

  20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367

    Article  CAS  PubMed  Google Scholar 

  21. Weber KT (2001) Cardioreparation in hypertensive heart disease. Hypertension 38:588–591

    Article  CAS  PubMed  Google Scholar 

  22. Xu J, Shiota T, Omoto R, Zhou X, Kyo S, Ishii M et al (1997) Intravascular ultrasound assessment of regional aortic wall stiffness, distensibility, and compliance in patients with coarctation of the aorta. Am Heart J 134:93–98

    Article  CAS  PubMed  Google Scholar 

Download references

Ethical statement

The procedure was approved by the committee on clinical investigation of each institution. Informed consent was obtained from all patients for being included in the study.

Conflict of interest

Hirokuni Yamazawa, Tomoaki Murakami, Atsuhito Takeda, Kouta Takei, Takuo Furukawa, Hiromichi Nakajima declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Hokkaido University School of Medicine, North 15 West 7, Kitaku, Sapporo, Hokkaido, 060-8638, Japan

    Hirokuni Yamazawa, Atsuhito Takeda, Kouta Takei & Takuo Furukawa

  2. Department of Pediatric Cardiology, Chiba Children’s Hospital, Chiba, Japan

    Tomoaki Murakami & Hiromichi Nakajima

Authors
  1. Hirokuni Yamazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomoaki Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsuhito Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kouta Takei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takuo Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiromichi Nakajima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hirokuni Yamazawa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamazawa, H., Murakami, T., Takeda, A. et al. Serum Concentration of Procollagen Type III Amino-Terminal Peptide is Increased in Patients with Successfully Repaired Coarctation of the Aorta with Left Ventricular Hypertrophy. Pediatr Cardiol 36, 555–560 (2015). https://doi.org/10.1007/s00246-014-1049-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-014-1049-5

Keywords

Search

Navigation